title: Management of moderate to severe psoriasis with systemic immunomodulatory therapies: a 5-year experience from two departments of dermatology of Northern France.
authors.forename: D
authors.initials: D
authors.lastname: Staumont-Sallé
authors.forename: V
authors.initials: V
authors.lastname: Florin
authors.forename: A C
authors.initials: AC
authors.lastname: Cottencin
authors.forename: G
authors.initials: G
authors.lastname: Chaby
authors.forename: E
authors.initials: E
authors.lastname: Delaporte
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D005602:France; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D012720:Severity of Illness Index; D055815:Young Adult
chemical_list: D000276:Adjuvants, Immunologic; D003879:Dermatologic Agents